aberrations and fit adequate to tolerate FCR therapy, should be good candidates for the latter, Using the profit becoming that this cure can be completed in 6 months though ibrutinib must be taken indefinitely.This methylation profile is already obtained for the MBL stage3 and continues to be rather stable as time passes. On the other hand, some CL